copper gluconate has been researched along with Neoplasms in 12 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 4 (33.33) | 18.7374 |
1990's | 1 (8.33) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 4 (33.33) | 24.3611 |
2020's | 3 (25.00) | 2.80 |
Authors | Studies |
---|---|
Cai, DH; Chen, BH; He, L; Le, XY; Liang, BF; Liu, QY; Pan, ZY | 1 |
Boggon, TJ; Chen, D; Chen, J; Dai, Q; DeBerardinis, R; Gao, X; Li, Y; Lim, E; Lin, R; Liu, S; Lonial, S; Mao, H; Metallo, C; Pan, Y; Shan, C; Vu, H; Wang, M; Wu, S; Xia, S; Zacharias, L; Zhao, L | 1 |
Dou, B; Li, L; Ma, J; Wang, J; Wang, N; Wen, Y; Zhao, K; Zheng, L | 1 |
Agarwal, N; Akerley, WL; Boucher, KM; Brittain-Blankenship, M; Buys, SS; Grossman, KF; Kelley, KC; Kennedy, TP; Kosak, KM; McGregor, KA; Sborov, DW; Shami, PJ; Sharma, S; Terrazas, MC; Thorne, KM; Ward, JH; Weis, JR; Werner, TL | 1 |
Chen, T; Du, W; Jiang, P; Sun, H; Xu, C; Yao, P; Zou, B | 1 |
Ma, Y; Mou, Q; Yan, D; Zhu, X | 1 |
Alečković, M; Arellano, ML; Boggon, TJ; Chen, GZ; Chen, J; Dai, Q; DeBerardinis, RJ; Elf, S; Fan, J; Gu, TL; He, C; Hitosugi, T; Jin, P; Kang, HB; Kang, S; Kang, Y; Khoury, HJ; Khuri, FR; Lee, BH; LeRoy, G; Lonial, S; Luan, CH; Muller, S; Owonikoko, TK; Seo, JH; Shan, C; Shin, DM; Sudderth, JA; Xie, J; Ye, K; Zhang, L; Zhou, L | 1 |
MANGIAROTTI, G; VERGNANO, C | 1 |
BONHAM, DG | 1 |
BRANDT, H; HUETER, J; TRAEGER, L; VORHERR, H | 1 |
Carmona, A | 1 |
Canon, C; Gil-Delgado, M; Mathé, G; Misset, JL; Musset, M; Reizenstein, P | 1 |
1 trial(s) available for copper gluconate and Neoplasms
Article | Year |
---|---|
A Phase 1 dose-escalation study of disulfiram and copper gluconate in patients with advanced solid tumors involving the liver using S-glutathionylation as a biomarker.
Topics: Adult; Aged; Aged, 80 and over; Disulfiram; Dose-Response Relationship, Drug; Female; Gluconates; Glutathione; Humans; Liver Neoplasms; Male; Middle Aged; Neoplasms | 2021 |
11 other study(ies) available for copper gluconate and Neoplasms
Article | Year |
---|---|
A novel water-soluble Cu(II) gluconate complex inhibits cancer cell growth by triggering apoptosis and ferroptosis related mechanisms.
Topics: Antineoplastic Agents; Apoptosis; Cell Line, Tumor; Coordination Complexes; Copper; DNA; Ferroptosis; Gluconates; Humans; Hydrogen Peroxide; Neoplasms; Serum Albumin, Human | 2023 |
γ-6-Phosphogluconolactone, a Byproduct of the Oxidative Pentose Phosphate Pathway, Contributes to AMPK Activation through Inhibition of PP2A.
Topics: A549 Cells; AMP-Activated Protein Kinase Kinases; AMP-Activated Protein Kinases; Animals; Cell Proliferation; Enzyme Activation; Gluconates; Glucosephosphate Dehydrogenase; HEK293 Cells; HT29 Cells; Humans; K562 Cells; MCF-7 Cells; Mice, Nude; Neoplasms; PC-3 Cells; Pentose Phosphate Pathway; Protein Binding; Protein Phosphatase 2; Protein Serine-Threonine Kinases; Reactive Oxygen Species; Ribulosephosphates; Signal Transduction; src-Family Kinases; Superoxide Dismutase; Tumor Burden | 2019 |
Characterization of chemical profiles of pH-sensitive cleavable D-gluconhydroximo-1, 5-lactam hydrolysates by LC-MS: A potential agent for promoting tumor-targeted drug delivery.
Topics: Antineoplastic Agents; Chromatography, High Pressure Liquid; Drug Carriers; Drug Compounding; Drug Design; Gluconates; Humans; Hydrogen-Ion Concentration; Hydrolysis; Lactams; Mass Spectrometry; Neoplasms; Phenylcarbamates; Prodrugs; Proof of Concept Study | 2020 |
Evidence for a direct cross-talk between malic enzyme and the pentose phosphate pathway via structural interactions.
Topics: Cell Line, Tumor; Gluconates; Humans; Hydro-Lyases; Malate Dehydrogenase; Mutation, Missense; NADP; Neoplasm Proteins; Neoplasms; Pentose Phosphate Pathway; Protein Multimerization; Signal Transduction | 2017 |
A small molecule nanodrug consisting of amphiphilic targeting ligand-chemotherapy drug conjugate for targeted cancer therapy.
Topics: Animals; Antibiotics, Antineoplastic; Apoptosis; Cell Line, Tumor; Cell Proliferation; Disaccharides; Doxorubicin; Drug Delivery Systems; Drug Liberation; Gluconates; Humans; Kidney; Lactones; Ligands; Liver; Male; Mice, Inbred BALB C; Mice, Nude; Nanoparticles; Neoplasms; Rats, Sprague-Dawley; Tumor Burden | 2016 |
Phosphoglycerate mutase 1 coordinates glycolysis and biosynthesis to promote tumor growth.
Topics: Animals; Binding, Competitive; Cell Line, Tumor; Cell Proliferation; Enzyme Activation; Gene Knockdown Techniques; Gluconates; Glucosephosphate Dehydrogenase; Glyceric Acids; Glycolysis; Humans; Mice; Mice, Nude; Models, Molecular; Neoplasms; Phosphoglycerate Mutase | 2012 |
[Dehydrogenase action on glucose-6-phosphate & 6-phosphogluconate in certain experimental tumors].
Topics: Animals; Encephalomyelitis; Gluconates; Glucose-6-Phosphate; Neoplasms; Neoplasms, Experimental; Oxidoreductases | 1958 |
[THE ACTIVITY OF PHOSPHO-6-GLUCONATE DEHYDROGENASE IN THE VAGINAL FLUID: NEW DIAGNOSTIC TEST FOR GENITAL CANCER].
Topics: Alcohol Oxidoreductases; Clinical Enzyme Tests; Cytodiagnosis; Diagnostic Tests, Routine; Equipment and Supplies; Female; Gluconates; Humans; Neoplasms; Oxidoreductases; Uterine Cervical Neoplasms; Uterine Neoplasms | 1964 |
[STUDIES ON THE SIGNIFICANCE OF ENZYME TESTS (GLUCOSE-6-PHOSPHATE-DEHYDROGENASE AND 6-PHOSPHOGLUCONATE-DEHYDROGENASE) FOR THE EARLY DETECTION OF GYNECOLOGICAL CANCER DISEASES].
Topics: Clinical Enzyme Tests; Female; Genital Diseases, Female; Genital Neoplasms, Female; Gluconates; Glucose-6-Phosphate; Glucosephosphate Dehydrogenase; Humans; Neoplasms; Phosphogluconate Dehydrogenase | 1965 |
[Drugs, inhibitors and other stories. From cancer chemotherapy to nutritional toxicology].
Topics: 6-Aminonicotinamide; Animals; Enzyme Inhibitors; Gluconates; Glycolysis; Isothiuronium; Neoplasms; Nutritional Physiological Phenomena; Oryza; Rats; Retrospective Studies; Tannins; Toxicology | 1999 |
A phase II trial of immunorestoration with zinc gluconate in immunodepressed cancer patients.
Topics: AIDS-Related Complex; Drug Evaluation; Gluconates; Humans; Leukocyte Count; Neoplasms; T-Lymphocytes; Zinc | 1986 |